within Pharmacolibrary.Drugs.ATC.L;

model L01XX74
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.45,
    Cl             = 0.2833333333333333,
    adminDuration  = 600,
    adminMass      = 0.12,
    adminCount     = 1,
    Vd             = 0.337,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.01,
    Tlag           = 10.200000000000001
  );

  annotation(Documentation(
    info ="<html><body><p>Belzutifan is an oral small molecule inhibitor of hypoxia-inducible factor-2α (HIF-2α). It is approved for the treatment of von Hippel-Lindau (VHL) disease-associated renal cell carcinoma, central nervous system hemangioblastomas, and pancreatic neuroendocrine tumors that do not require immediate surgery. The drug is currently approved and in clinical use.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported in adult patients with cancer receiving oral belzutifan 120 mg once daily.</p><h4>References</h4><ol><li><p>Marathe, DD, et al., &amp; Jain, L (2024). Exposure-Response Analyses for Belzutifan to Inform Dosing Considerations and Labeling. <i>Journal of clinical pharmacology</i> 64(10) 1246–1258. DOI:<a href=&quot;https://doi.org/10.1002/jcph.2459&quot;>10.1002/jcph.2459</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/38752556/&quot;>https://pubmed.ncbi.nlm.nih.gov/38752556</a></p></li><li><p>Marathe, DD, et al., &amp; Jain, L (2023). Population pharmacokinetic analyses for belzutifan to inform dosing considerations and labeling. <i>CPT: pharmacometrics &amp; systems pharmacology</i> 12(10) 1499–1510. DOI:<a href=&quot;https://doi.org/10.1002/psp4.13028&quot;>10.1002/psp4.13028</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/37596839/&quot;>https://pubmed.ncbi.nlm.nih.gov/37596839</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end L01XX74;
